BridgeBio Oncology (BBOT)

• Market cap: $977M
• 1 day: -0.81%
• 5 days: -1.21%
• 1 month: -0.65%
• 3 months: 27.45%
• 6 months: 13.9%
• Year to date: 11.1%
• 1 year: 16.29%
• 5 years: 19.82%
• 10 years: 19.82%
• Sector: Healthcare
• Industry: Biotechnology

About: BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Employees: 81